[Congressional Record Volume 145, Number 131 (Friday, October 1, 1999)]
[Senate]
[Pages S11757-S11761]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]




  DEPARTMENTS OF LABOR, HEALTH AND HUMAN SERVICES, AND EDUCATION, AND 
               RELATED AGENCIES APPROPRIATIONS ACT, 2000

  The PRESIDING OFFICER. Also, under the previous order, the Senate 
will now resume consideration of S. 1650, which the clerk will report.
  The legislative clerk read as follows:

       A bill (S. 1650) making appropriations for the Departments 
     of Labor, Health and Human Services, and Education, and 
     Related Agencies for the fiscal year ending September 30, 
     2000, and for other purposes.

  The PRESIDING OFFICER. Under the previous order, the Senator from 
Maine is recognized to offer amendment No. 1824 on which there will be 
30 minutes of debate equally divided.
  The Senator from Maine.
  Ms. COLLINS. I thank the Chair.


                           Amendment No. 1824

  (Purpose: To express the sense of the Senate that diabetes and its 
 resulting complications have had a devastating impact on Americans of 
 all ages in both human and economic terms, and that increased support 
  for research, education, early detection, and treatment efforts is 
necessary to take advantage of unprecedented opportunities for progress 
      toward better treatments, prevention, and ultimately a cure)

  Mr. President, I do call up amendment No. 1824, which is at the desk, 
and ask for its immediate consideration.
  The PRESIDING OFFICER. The clerk will report.

[[Page S11758]]

  The legislative clerk read as follows:

       The Senator from Maine [Ms. Collins], for herself, Mr. 
     Breaux, and Mr. Grassley, proposes an amendment numbered 
     1824.

  Ms. COLLINS. Mr. President, I ask unanimous consent that reading of 
the amendment be dispensed with.
  The PRESIDING OFFICER. Without objection, it is so ordered.
  The amendment is as follows:

       At the appropriate place in title II, insert the following:

     SEC. ----. EXPRESSING THE SENSE OF THE SENATE TO RAISE THE 
                   AWARENESS OF THE DEVASTATING IMPACT OF DIABETES 
                   AND TO SUPPORT INCREASED FUNDS FOR DIABETES 
                   RESEARCH.

       (a) Findings.--Congress makes the following findings:
       (1) Diabetes is a devastating, lifelong condition that 
     affects people of every age, race, income level, and 
     nationality.
       (2) Sixteen million Americans suffer from diabetes, and 
     millions more are at risk of developing the disease.
       (3) The number of Americans with diabetes has increased 
     nearly 700 percent in the last 40 years, leading the Centers 
     for Disease Control and Prevention to call it the ``epidemic 
     of our time''.
       (4) In 1999, approximately 800,000 people will be diagnosed 
     with diabetes, and diabetes will contribute to almost 200,000 
     deaths, making diabetes the sixth leading cause of death due 
     to disease in the United States.
       (5) Diabetes costs our nation an estimated $105,000,000,000 
     each year.
       (6) More than 1 out of every 10 United States health care 
     dollars, and about 1 out of every 4 Medicare dollars, is 
     spent on the care of people with diabetes.
       (7) More than $40,000,000,000 a year in tax dollars are 
     spent treating people with diabetes through Medicare, 
     Medicaid, veterans benefits, Federal employee health 
     benefits, and other Federal health programs.
       (8) Diabetes frequently goes undiagnosed, and an estimated 
     5,400,000 Americans have the disease but do not know it.
       (9) Diabetes is the leading cause of kidney failure, 
     blindness in adults, and amputations.
       (10) Diabetes is a major risk factor for heart disease, 
     stroke, and birth defects, and shortens average life 
     expectancy by up to 15 years.
       (11) An estimated 1,000,000 Americans have Type 1 diabetes, 
     formerly known as juvenile diabetes, and 15,200,000 Americans 
     have Type 2 diabetes, formerly known as adult-onset diabetes.
       (12) Of Americans aged 65 years or older, 18.4 percent have 
     diabetes.
       (13) Of Americans aged 20 years or older, 8.2 percent have 
     diabetes.
       (14) Hispanic, African, Asian, and Native Americans suffer 
     from diabetes at rates much higher than the general 
     population, including children as young as 8 years-old, who 
     are now being diagnosed with Type 2 diabetes, formerly known 
     as adult-onset diabetes.
       (15) In 1999, there is no method to prevent or cure 
     diabetes, and available treatments have only limited success 
     in controlling diabetes devastating consequences.
       (16) Reducing the tremendous health and human burdens of 
     diabetes and its enormous economic toll depend on identifying 
     the factors responsible for the disease and developing new 
     methods for treatment and prevention.
       (17) Improvements in technology and the general growth in 
     scientific knowledge have created unprecedented opportunities 
     for advances that might lead to better treatments, 
     prevention, and ultimately a cure.
       (18) After extensive review and deliberations, the 
     congressionally established and National Institutes of 
     Health-selected Diabetes Research Working Group has found 
     that ``many scientific opportunities are not being pursued 
     due to insufficient funding, lack of appropriate mechanisms, 
     and a shortage of trained researchers''.
       (19) The Diabetes Research Working Group has developed a 
     comprehensive plan for National Institutes of Health-funded 
     diabetes research, and has recommended a funding level of 
     $827,000,000 for diabetes research at the National Institutes 
     of Health in fiscal year 2000.
       (20) The Senate as an institution, and Members of Congress 
     as individuals, are in unique positions to support the fight 
     against diabetes and to raise awareness about the need for 
     increased funding for research and for early diagnosis and 
     treatment.
       (b) Sense of the Senate.--It is the sense of the Senate 
     that--
       (1) the Federal Government has a responsibility to--
       (A) endeavor to raise awareness about the importance of the 
     early detection, and proper treatment of, diabetes; and
       (B) continue to consider ways to improve access to, and the 
     quality of, health care services for screening and treating 
     diabetes;
       (2) the National Institutes of Health, within their 
     existing funding levels, should increase research funding, as 
     recommended by the congressionally established and National 
     Institutes of Health-selected Diabetes Research Working 
     Group, so that the causes of, and improved treatments and 
     cure for, diabetes may be discovered;
       (3) all Americans should take an active role to fight 
     diabetes by using all the means available to them, including 
     watching for the symptoms of diabetes, which include frequent 
     urination, unusual thirst, extreme hunger, unusual weight 
     loss, extreme fatigue, and irritability; and
       (4) national organizations, community organizations, and 
     health care providers should endeavor to promote awareness of 
     diabetes and its complications, and should encourage early 
     detection of diabetes through regular screenings, education, 
     and by providing information, support, and access to 
     services.

  The PRESIDING OFFICER. The Senator from Maine is recognized.
  Ms. COLLINS. Mr. President, I ask unanimous consent that the Senator 
from Michigan, Mr. Abraham, be added as a cosponsor of this amendment.
  The PRESIDING OFFICER. Without objection, it is so ordered.
  Ms. COLLINS. I thank the Chair.
  Mr. President, I am pleased to join my co-chair of the Senate 
Diabetes Caucus, Senator Breaux, as well as the chairman of the Senate 
Special Committee on Aging, Senator Grassley, and the distinguished 
Senator from Michigan, Mr. Abraham, in introducing a sense-of-the-
Senate resolution to help address the devastating impact of diabetes 
and its resulting complications on Americans of all ages.
  This resolution calls for increased support for diabetes research, 
education, early detection, and treatment. Diabetes research has been 
underfunded in recent years. It is imperative that we increase our 
commitment in order to take full advantage of the unprecedented and 
exciting scientific opportunities that we have as the millennium 
approaches for advances leading to better detection, treatment, 
prevention, and ultimately a cure for this devastating disease.
  Diabetes is a very serious condition that affects people of every 
age, race, and nationality. Here in America, 16 million people suffer 
from diabetes, and about 800,000 new cases are diagnosed each year.
  Moreover, diabetes frequently goes undiagnosed. Of the 16 million 
Americans with diabetes, it is estimated that 5.4 million do not 
realize they have this very serious condition.
  Diabetes is one of our Nation's most costly diseases, both in human 
and economic terms. It is the sixth deadliest disease in the United 
States and kills almost 200,000 Americans annually. It is the leading 
cause of kidney failure, of blindness in adults, and amputations. It is 
a significant risk factor for heart disease, stroke, and birth defects. 
The disease shortens the average life expectancy by up to 15 years
  Moreover, it is very costly in financial terms as well. Diabetes 
costs the Nation in excess of $105 billion annually in health-related 
expenditures. At present, more than 1 out of every 10 dollars that we 
spend on health care is related to treating people with diabetes. About 
1 out of 4 Medicare dollars are used to treat people with diabetes. 
Indeed, more than 40 billion in tax dollars is spent each year treating 
people with diabetes through Medicare, Medicaid, veterans' health, and 
Federal employees' programs.
  Unfortunately, there currently is no way to prevent or to cure 
diabetes. Available treatments have had only limited success in 
controlling the devastating consequences of this disease. This problem 
is made all the more complex by the fact that diabetes is not a single 
disease, but rather it occurs in several forms and the complications 
affect virtually every system of the body.
  Children with type I diabetes face a lifetime of multiple daily 
finger pricks to check their blood sugar levels, daily insulin 
injections, and the possibility of lifelong complications, including 
kidney failure and blindness, which can be deadly, can be disabling.
  Older Americans with diabetes also can be disabled by the multiple 
complications of the disease.
  Every year, the Juvenile Diabetes Foundation hosts a children's 
congress in Washington, DC. They bring children from all over this 
Nation to put a human face on the consequences of type I diabetes.
  Recently, I had the opportunity to meet a courageous 8-year-old boy 
from North Yarmouth, ME. Nathan Reynolds is an active young boy. He 
loves school, biking, swimming, and baseball, and he particularly likes 
collecting old coins. He is also suffering from type I diabetes. He was 
diagnosed about 2 years ago, and it has completely changed his life and 
the life of his family.
  He has had to learn how to check his blood. In fact, his 4-year-old 
brother reminds him to do it before each meal.

[[Page S11759]]

He has to give himself an insulin shot or get his teacher or the school 
nurse or his parents to help him do so. Nathan can never take a day off 
from his disease. It does not matter whether it is Christmas or his 
birthday, he still has to prick his finger and check his blood sugar. 
He still has to inject himself with insulin in order to keep relatively 
healthy.
  I will never forget the story a teacher told me of all the children 
in her class making a wish for Christmas. Some of them wished for a new 
toy, one wished for a pony, another wished to go to Disney World. But 
one little boy who had juvenile diabetes made the wish that he could 
just have Christmas without having to give himself ``yucky'' shots.
  That story touched me deeply, and it hit home with the fact that this 
is a lifelong condition for children who are diagnosed with type I 
diabetes.
  I will also never forget the anguish on a young mother's face who 
told me her 5-year-old son had just been diagnosed with diabetes. ``How 
do I tell him?'' she said. ``How do I tell him he is going to have to 
have shots every day, that he is going to have to constantly prick his 
finger to check his blood sugar levels? How do I tell him what this 
means for him and for all of us who love him?''
  There is also some good news. Exciting research is underway that 
should lead to medical breakthroughs for Nathan, for other children, 
and for adults who have type I and type II diabetes. Reducing the 
tremendous health and human burdens of diabetes and its enormous 
economic toll depends upon identifying the factors responsible for the 
disease and developing new methods for treatment, prevention, and 
ultimately a cure.
  The next decade holds tremendous potential and promise for diabetes 
research. Improvements in technology and the general growth in 
scientific knowledge have created unprecedented opportunities for 
advancements that might lead to better treatments, prevention, and a 
cure.

  Earlier this year, the congressionally mandated diabetes research 
working group, an independent panel composed of 12 scientific experts 
of diabetes and 4 representatives of the lay diabetes communities, 
issued an important report. It is called ``Conquering Diabetes: A 
Strategic Plan for the 21st Century.'' This important report details 
the magnitude of the problem, and it lays out a comprehensive plan for 
research conducted by the National Institutes of Health on diabetes.
  In this report, the diabetes working group found, ``Many scientific 
opportunities are not being pursued due to insufficient funding, lack 
of appropriate mechanisms and a shortage of trained researchers.''
  The report also concluded that the current level of funding, the 
level of effort, and the scope of diabetes research falls far short of 
what is needed to capitalize on these promising opportunities. The 
funding level, the report found, is so far short of what is required to 
make progress on this complex and difficult problem.
  The report goes on to recommend a funding level of $827 million for 
diabetes research at NIH in fiscal year 2000, and, indeed, many of our 
colleagues signed a letter to the Appropriations Committee requesting 
an appropriation of just that level to be included to advance the goals 
of this legislation.
  I am a strong supporter of increased research and of efforts to 
double our investment in biomedical research over the next few years. 
There is simply no investment that would yield greater returns for the 
American taxpayers, and the commitment of the bill before us of an 
additional $2 billion in funding for NIH, which represents nearly a 13-
percent increase, will bring us so much closer to that goal. This 
strategy is particularly important as we move into the next century 
when our public health and disability programs will be under increasing 
strains due to the aging of our population.
  I am also very pleased and commend the chairman of the subcommittee, 
Senator Specter, and the ranking minority member, Senator Harkin, for 
including very strong language in the report accompanying this bill 
which recognizes that diabetes research has been underfunded in the 
past and directs that funding for diabetes be increased at the National 
Institute for Diabetes and Digestive and Kidney Disease and other NIH 
institutes. Again, the chairman of the Appropriations Committee, 
Senator Stevens, and the chairman and ranking member of the 
subcommittee, Senator Specter and Senator Harkin, have all been 
tremendous advocates for people with diabetes and are to be commended 
for their strong leadership in this effort.
  The amendment I am offering today does not earmark a particular 
funding level for diabetes research. Rather, it is intended to heighten 
awareness of the devastating impact of this disease, and it is intended 
to affirm that diabetes research is a high priority. Most of all, the 
amendment expresses the clear intent of the Senate that the National 
Institutes of Health should substantially increase its investment in 
the fight against diabetes along the lines recommended in this landmark 
report, the $827 million recommendation.
  We must ensure that sufficient resources are available to take full 
advantage of the extraordinary and unprecedented scientific 
opportunities identified by the diabetes working group. If we do so, we 
can better understand and ultimately conquer this devastating disease.
  I thank the Chair for his attention. I hope all of my colleagues will 
join us in supporting this resolution to send a clear signal that we 
are committed to conquering diabetes.
  I reserve any remaining time I may have left.
  Mr. GRASSLEY. Mr. President, I rise today in support of the sense-of-
the-Senate resolution regarding diabetes. I thank my colleagues from 
Maine for sponsoring this resolution. Senator Collins and I were among 
the original co-founders of the Senate Diabetes Caucus and have worked 
together to raise awareness of the disease and the need for a cure.
  Diabetes is a devastating illness that affects people of every age, 
race, and nationality. More than sixteen million Americans suffer from 
diabetes and 800,000 new cases are diagnosed each year. Diabetes is 
also a leading chronic illness affecting children, a special population 
with which it places an especially heavy burden.
  Although many people with diabetes are able to survive with multiple 
daily injections of insulin, it is not a cure for this dreaded disease. 
Despite the availability of insulin, diabetes continues to cause 
serious health complications, including kidney failure and blindness, 
and it is the cause of nearly 200,000 deaths per year.
  Diabetes costs our nation nearly $100 billion each year in direct and 
indirect costs. In fact, more than forty billion tax dollars are spent 
each year in treating people with diabetes through Medicare, Medicaid, 
veterans and federal employees health benefits.
  Past investments in diabetes research at the National Institutes for 
Health (NIH) are beginning to show real promise for a cure and the 
number of research opportunities in the field continue to expand. We 
now stand at a pivotal juncture in the fight to cure diabetes and its 
complications.
  A report released in February by the congressionally mandated 
Diabetes Research Working Group (DRWG) called upon NIH to substantially 
expand its support for diabetes research and has identified specific 
research recommendations as part of a new national plan to find a cure.
  On April 26, 1999, a letter signed by myself, Senator Collins, and 37 
of our colleagues was sent to Chairman Specter and Ranking Member 
Harkin in requesting increased funding for diabetes research within NIH 
in accordance with the DRWG report. And, it is clear from the work of 
the Senate Appropriations Committee that diabetes has not been 
neglected. Therefore, in an effort to bolster the work of the 
committee, and I believe rightly so, this resolution is being 
introduced today to send a clear signal to all Americans that diabetes 
is a serious concern of the United States Senate.
  We have not yet found a cure for diabetes. But, I am confident that 
in time and with sufficient support, a cure will be found and we will 
be able to declare victory over this debilitating disease.
  Mr. SPECTER addressed the Chair.
  The PRESIDING OFFICER. The Senator from Pennsylvania.
  Mr. SPECTER. Mr. President, I congratulate the distinguished Senator 
from Maine, Ms. Collins, for offering this amendment. I agree with her 
that the amendment will appropriately

[[Page S11760]]

focus attention on the problems of diabetes, especially among the young 
people in America.
  I thank Senator Collins for noting the work of the subcommittee and 
the full committee in moving ahead with funding on this important 
ailment and, as she noted, with the very strong language that is 
present in the bill encouraging the National Institutes of Health to 
move forward.
  I think it appropriate to note for the record that on June 22 of this 
year we had a special hearing on diabetes. At that time, we had 
testimony from officials at the National Institutes of Health, the 
Director, Dr. Harold Varmus; Dr. Phillip Gorton, the Director of the 
Institute of Diabetes and Digestive and Kidney Diseases; as well as a 
number of others.
  It is very important to put a human face on the issue, as Senator 
Collins did with the specific reference in her speech to the 
youngsters. At that time, we had coming forward the celebrity, Mary 
Tyler Moore, a juvenile diabetic; Mr. Tony Bennett, the famous singer, 
the grandfather of a child with diabetes; Mr. Alan Silvestri, a 
composer and father of a child with diabetes; and also our 
distinguished colleague, Senator Strom Thurmond, who has a daughter 
with diabetes.
  It is a curious factor, but a fact of life nonetheless, that when 
people of celebrated stature come and testify, there is more public 
understanding of the ailment and more willingness to face up to it in 
the appropriations process.
  In order to carry forward on what this sense-of-the-Senate resolution 
requests--and I feel confident in predicting it will pass 90-something 
to nothing; the only open question is how many Senators will be present 
to vote for it; I think it will be a unanimous vote, but our ability to 
carry that forward depends upon what we appropriate.
  In the bill currently pending, we have an increase in NIH funding of 
$2 billion. That is a tremendous sum of money. We have a bill which is 
$4 billion higher than last year's bill, with the funding coming 
largely for education, where we have an increase of $2.3 billion. In 
assessing the priorities in education, we have put in more than $500 
million more than the President's request. We have in excess of $35 
billion for education.
  When it comes to health care, Senator Harkin and I have taken the 
lead in adding $2 billion, as we did last year. When we have assessed 
those priorities, it has made it necessary to reduce funding on some 
other proposals. I found myself in a very unique position in managing 
this bill. I have voted against amendments I never voted against 
before. I voted against an amendment to add $200 million on class size, 
which I would like to have supported. The bill continues the funding at 
$1.2 billion. If we added the $200 million on class size, in addition 
to the $1.2 billion, there would not be room for funding for NIH, for 
programs such as diabetes.
  Then we had an amendment come up on afterschool programs, again, a 
request for $200 million more. There is $200 million in the current 
budget, and Senator Harkin and I took the lead of adding $200 million 
to bring it to $400 million. I would like to have more for afterschool 
programs, but I had to vote against that amendment, because if we add 
$200 million more to afterschool programs, it has to come from some 
place. And NIH is a big target out there. The amendment adding the $200 
million for afterschool programs was offered by the Senator from 
California, Mrs. Boxer.

  Then Senator Dodd offered an amendment to add about $900 million more 
to day care. I have always supported. But again, when you have a bill 
of $91.7 billion, which is at the breaking point as to what this body 
will pass--and I think there is a question as to whether we will have 
51 votes for that because it is a lot of money, although staying within 
the caps--again with great reluctance, I could not support Senator 
Dodd's amendment on day care.
  Then we had a very important social service block grant, again where 
it is a matter of priorities. When it comes to health, I believe there 
is no higher priority. I have said with some frequency that the 
National Institutes of Health is the crown jewel of the Federal 
Government--perhaps the only jewel of the Federal Government.
  In my position as chairman of the subcommittee, which has the 
baseline responsibility to fund the National Institutes of Health--and 
Senator Harkin has the same consideration--we receive requests 
constantly from people who have Parkinson's--we had a hearing this week 
on Parkinson's disease. We had a hearing on prostate cancer, a special 
concern on breast cancer, heart ailments, a very large number of 
unknown diseases.
  I said on the floor yesterday that Senator Harkin is very frequently 
lobbied when he gets on the plane between Washington and Des Moines. I 
find a lot of people with unique ailments on the Metroliner between 
Washington and Philadelphia.
  As Senator Collins has brought forward the issue this morning, I 
think it is a very profound message. But to accomplish what Senator 
Collins seeks, we have to appropriate the increase of $2 billion. Even 
then, if there are 10 doors with research projects behind them, 7 of 
those doors will not be opened, even with funding NIH at a level of 
$17.6 billion.
  So again, I thank my colleague from Maine--carrying on the great 
tradition of Maine Senators.
  I yield the floor, leaving her the remainder of the time before 9:30 
to close.
  Ms. COLLINS addressed the Chair.
  The PRESIDING OFFICER. The Senator from Maine.
  Ms. COLLINS. I again salute the Senator from Pennsylvania for his 
tremendous commitment to medical research. Without his leadership, we 
would not see the kinds of advancements that are being made. I thank 
him for his support.
  Mr. President, I ask unanimous consent the Senator from Ohio, Mr. 
DeWine, and the Senator from Arkansas, Mr. Hutchinson, be added as 
cosponsors to my sense-of-the-Senate amendment.
  The PRESIDING OFFICER. Without objection, it is so ordered.
  Ms. COLLINS. Mr. President, we are on the edge of an exciting 
breakthrough in the treatment and ultimately the prevention and cure of 
diabetes. That is why I am so excited by the possibility of a 
significant increase in research in this area.
  As the chairman of the Senate Diabetes Caucus, I have had the 
opportunity to visit some of the leading-edge research labs that are 
doing work on diabetes. I have visited Jackson Labs in Bar Harbor, MA, 
where very exciting research is ongoing into the causes of both type I 
and type II diabetes. I am very proud of the contributions made by 
these distinguished scientists in my home State.
  In addition, I have had the pleasure of visiting the JDF Foundation 
Center at Harvard Medical School, where there is also tremendous 
research underway. I am convinced, with the kind of increased 
commitment called for by my resolution, and indicated in the 
Appropriations Committee's report, that we can in fact break through 
and reach a cure for this devastating disease.
  Mr. President, I do not know whether there is any other request for 
time. It is my understanding the vote is scheduled for 9:30. We have 
reached that hour.
  Mr. President, seeing no one seeking further time to speak, I ask for 
the yeas and nays on the pending amendment.
  The PRESIDING OFFICER. Is there a sufficient second? There appears to 
be a sufficient second.
  The yeas and nays were ordered.
  The PRESIDING OFFICER. Is all time yielded back? Does the Senator 
from Pennsylvania yield back the remaining time?
  Mr. SPECTER. I do, Mr. President. The hour is 9:30. I think we are 
set for the vote.
  The PRESIDING OFFICER. All time having expired, the question is on 
agreeing to the Collins amendment No. 1824. The yeas and nays have been 
ordered. The clerk will call the roll.
  The legislative clerk called the roll.
  Mr. NICKLES. I announce that the Senator from Indiana (Mr. Lugar), 
the Senator from Florida (Mr. Mack), the Senator from Arizona (Mr. 
McCain), and the Senator from Wyoming (Mr. Thomas), are necessarily 
absent
  Mr. REID. I announce that the Senator from California (Mrs. Boxer) 
and the Senator from Oregon (Mr. Wyden) are necessarily absent.

[[Page S11761]]

  I also announce that the Senator from Michigan (Mr. Levin) is absent 
because of a death in the family.
  I further announce that, if present and voting, the Senator from 
Michigan (Mr. Levin) would vote ``no.''
  The result was announced--yeas 93, nays 0, as follows:

                      [Rollcall Vote No. 305 Leg.]

                                YEAS--93

     Abraham
     Akaka
     Allard
     Ashcroft
     Baucus
     Bayh
     Bennett
     Biden
     Bingaman
     Bond
     Breaux
     Brownback
     Bryan
     Bunning
     Burns
     Byrd
     Campbell
     Chafee
     Cleland
     Cochran
     Collins
     Conrad
     Coverdell
     Craig
     Crapo
     Daschle
     DeWine
     Dodd
     Domenici
     Dorgan
     Durbin
     Edwards
     Enzi
     Feingold
     Feinstein
     Fitzgerald
     Frist
     Gorton
     Graham
     Gramm
     Grams
     Grassley
     Gregg
     Hagel
     Harkin
     Hatch
     Helms
     Hollings
     Hutchinson
     Hutchison
     Inhofe
     Inouye
     Jeffords
     Johnson
     Kennedy
     Kerrey
     Kerry
     Kohl
     Kyl
     Landrieu
     Lautenberg
     Leahy
     Lieberman
     Lincoln
     Lott
     McConnell
     Mikulski
     Moynihan
     Murkowski
     Murray
     Nickles
     Reed
     Reid
     Robb
     Roberts
     Rockefeller
     Roth
     Santorum
     Sarbanes
     Schumer
     Sessions
     Shelby
     Smith (NH)
     Smith (OR)
     Snowe
     Specter
     Stevens
     Thompson
     Thurmond
     Torricelli
     Voinovich
     Warner
     Wellstone

                             NOT VOTING--7

     Boxer
     Levin
     Lugar
     Mack
     McCain
     Thomas
     Wyden
  The amendment (No. 1824) was agreed to.
  Mr. COVERDELL. I move to reconsider the vote.
  Mr. HATCH. I move to lay that motion on the table.
  The motion to lay on the table was agreed to.
  Mr. DASCHLE. Mr. President, I ask to proceed as in morning business.
  The PRESIDING OFFICER (Mr. Gorton). Without objection, it is so 
ordered

                          ____________________